Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer

NCT04731909 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT04731909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04731909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Toripalimab Combined With Anlotinib, Etoposide and Platinum in the Treatment of Extensive-stage Small Cell Lung Cancer
Lead sponsor
Third Military Medical University
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2018
Completion date
June 30, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer, sclc, extensive stage, small cell lung cancer